Nuvalent Inc is a biotechnology company focused on developing targeted therapies for cancer patients. Their innovative approach combines precision medicine and advanced drug discovery technologies to create personalized treatments.

Currently, NUVA stock is retesting a logical level of support. This indicates that the stock price is revisiting a key price level where buyers have historically shown interest, potentially leading to a bounce or a reversal in the stock's direction. Traders and investors closely monitor these support levels as they can provide valuable insights into future price movements.

If NUVA manages to hold above the 61 support level, it suggests a higher bias in the stock. This means that there is a greater likelihood of the stock price continuing its upward trend. Traders should keep a close eye on NUVA's price action and volume to confirm the strength of the support level and make informed trading decisions.